Gene expression profiling of CD4+ T cells in treatment-naive HIV, HCV mono- or co-infected Chinese

Virology Journal

Volumn 11, Issue 1, 2014, Pages

  Yi, Lina ^a,c   Zhao, Jin ^a,b   Lu, Jing ^c   Chen, Ying ^a   Chen, Lin ^b   Cheng, Jinquan ^b   Sun, Yan ^d   Li, Zhi ^d   Men, Ruotin ^e   Yang, Li ^e   Kung, Hsiangfu ^a   Yang, Zhengrong ^b   He, Ming Liang ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b SHENZHEN CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c GUANGZHOU CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^d SHANXI NORMAL UNIVERSITY   (China)

^e SICHUAN UNIVERSITY   (China)

Author keywords

Co infection; HCV; HIV; Microarray

Indexed keywords

AQUAPORIN 9; CHEMOKINE RECEPTOR CX3CR1; G PROTEIN COUPLED RECEPTOR; INTERLEUKIN 6; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; PENTRAXIN 3; TOLL LIKE RECEPTOR 4;

AMINO ACID METABOLISM; ARTICLE; CD4+ T LYMPHOCYTE; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CHINESE; COMPLEMENT ACTIVATION; G2 PHASE CELL CYCLE CHECKPOINT; GENE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNE RESPONSE GENE; IMMUNITY; INNATE IMMUNITY; METABOLISM; MIXED INFECTION; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NONHUMAN; OAS1 GENE; P2RY13 GENE; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STIMULUS RESPONSE; UPREGULATION; USP18 GENE;

HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS;

ADOLESCENT; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CD4-POSITIVE T-LYMPHOCYTES; GENE EXPRESSION PROFILING; HEPATITIS C; HIV INFECTIONS; HUMANS; MALE; MICROARRAY ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; YOUNG ADULT;

EID: 84893636347     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-11-27     Document Type: Article

References (45)

1. Molecular epidemiology of HCV monoinfection and HIV/HCV coinfection in injection drug users in Liuzhou, Southern China. Tan Y, Wei QH, Chen LJ, Chan PC, Lai WS, He ML, Kung HF, Lee SS, PLoS One 2008 3 3608 10.1371/journal.pone. 0003608 18974888
2. Epidemiology of viral hepatitis and HIV co-infection. Alter MJ, J Hepatol 2006 44 6 S9 16352363
3. Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drug users. Thomas DL, Shih JW, Alter HJ, Vlahov D, Cohn S, Hoover DR, Cheung L, Nelson KE, J Infect Dis 1996 174 690 695 10.1093/infdis/174.4.690 8843204
4. [Study on the epidemiology and HCV genotype distribution of HIV/HCV co-infection among HIV infected blood donors in China]. Liu Z, Xing WG, Zhang YH, Zhang Q, Long XS, Zhang GY, Wu H, Jiang Y, Zhonghua Gan Zang Bing Za Zhi 2006 14 464 465 16792877
5. Relation between HIV-1 and hepatitis C viral load in patients with hemophilia. Daar ES, Lynn H, Donfield S, Gomperts E, Hilgartner MW, Hoots WK, Chernoff D, Arkin S, Wong WY, Winkler CA, J Acquir Immune Defic Syndr 2001 26 466 472 10.1097/00126334-200104150-00011 11391167
6. High hepatitis C viraemia and impaired antibody response in patients coinfected with HIV. Cribier B, Rey D, Schmitt C, Lang JM, Kirn A, Stoll-Keller F, AIDS 1995 9 1131 1136 10.1097/00002030-199510000-00003 8519448
7. Progression of chronic hepatitis C to liver fibrosis and cirrhosis in patients coinfected with hepatitis C virus and human immunodeficiency virus. Martinez-Sierra C, Arizcorreta A, Diaz F, Roldan R, Martin-Herrera L, Perez-Guzman E, Giron-Gonzalez JA, Clin Infect Dis 2003 36 491 498 10.1086/367643 12567308
8. Survival and prognostic factors of HIV-infected patients with HCV-related end-stage liver disease. Merchante N, Giron-Gonzalez JA, Gonzalez-Serrano M, Torre-Cisneros J, Garcia-Garcia JA, Arizcorreta A, Ruiz-Morales J, Cano-Lliteras P, Lozano F, Martinez-Sierra C, Macías J, Pineda JA, Grupo Andaluz para el Estudio de las Enfermedades Infecciosas, AIDS 2006 20 49 57 10.1097/01.aids.0000198087.47454.e1 16327319
9. Risk of developing specific AIDS-defining illnesses in patients coinfected with HIV and hepatitis C virus with or without liver cirrhosis. d'Arminio Monforte A, Cozzi-Lepri A, Castagna A, Antinori A, De Luca A, Mussini C, Caputo SL, Arlotti M, Magnani G, Pellizzer G, Maggiolo F, Puoti M, for the Icona Foundation Study Group, Clin Infect Dis 2009 49 612 622 10.1086/603557 19591597
10. Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy. Rockstroh JK, Mocroft A, Soriano V, Tural C, Losso MH, Horban A, Kirk O, Phillips A, Ledergerber B, Lundgren J, J Infect Dis 2005 192 992 1002 10.1086/432762 16107951
11. Distinct transcriptional profiles in ex vivo CD4+ and CD8+ T cells are established early in human immunodeficiency virus type 1 infection and are characterized by a chronic interferon response as well as extensive transcriptional changes in CD8+ T cells. Hyrcza MD, Kovacs C, Loutfy M, Halpenny R, Heisler L, Yang S, Wilkins O, Ostrowski M, Der SD, J Virol 2007 81 3477 3486 10.1128/JVI.01552-06 17251300
12. CD8(+) T cell activation in women coinfected with human immunodeficiency virus type 1 and hepatitis C virus. Kovacs A, Al-Harthi L, Christensen S, Mack W, Cohen M, Landay A, J Infect Dis 2008 197 1402 1407 10.1086/587696 18444798
13. Underlying pathophysiology of HCV infection in HIV-positive drug users. Balasubramanian A, Groopman JE, Ganju RK, J Addict Dis 2008 27 75 82 10.1300/J069v27n02-09 18681194
14. Polyfunctional HCV-specific T-cell responses are associated with effective control of HCV replication. Ciuffreda D, Comte D, Cavassini M, Giostra E, Buhler L, Perruchoud M, Heim MH, Battegay M, Genne D, Mulhaupt B, Malinverni R, Oneta C, Bernasconi E, Monnat M, Cerny A, Chuard C, Borovicka J, Mentha G, Pascual M, Gonvers JJ, Pantaleo G, Dutoit V, Eur J Immunol 2008 38 2665 2677 10.1002/eji.200838336 18958874
15. T cells and viral persistence: lessons from diverse infections. Klenerman P, Hill A, Nat Immunol 2005 6 873 879 10.1038/ni1241 16116467
16. HCV-HIV coinfection: simple messages from a complex disease. Klenerman P, Kim A, PLoS Med 2007 4 240 10.1371/journal.pmed.0040240 17927445
17. HIV-specific CD4 T cells and immune control of viral replication. Porichis F, Kaufmann DE, Curr Opin HIV AIDS 2011 6 3 174 180 10.1097/COH.0b013e3283454058 21502921
18. HIV-1 Vif promotes the G- to S-phase cell-cycle transition. Wang J, Reuschel EL, Shackelford JM, Jeang L, Shivers DK, Diehl JA, Yu XF, Finkel TH, Blood 2011 117 1260 1269 10.1182/blood-2010-06-289215 21149631
19. Human immunodeficiency virus type 1 can establish latent infection in resting CD4+ T cells in the absence of activating stimuli. Swiggard WJ, Baytop C, Yu JJ, Dai J, Li C, Schretzenmair R, Theodosopoulos T, O'Doherty U, J Virol 2005 79 14179 14188 10.1128/JVI.79.22.14179-14188.2005 16254353
20. Repair of gaps in retroviral DNA integration intermediates. Yoder KE, Bushman FD, J Virol 2000 74 11191 11200 10.1128/JVI.74.23.11191-11200.2000 11070016
21. siRNA screening of a targeted library of DNA repair factors in HIV infection reveals a role for base excision repair in HIV integration. Espeseth AS, Fishel R, Hazuda D, Huang Q, Xu M, Yoder K, Zhou H, PLoS One 2011 6 17612 10.1371/journal.pone.0017612 21448273
22. Human immunodeficiency virus type 1 cell cycle control: Vpr is cytostatic and mediates G2 accumulation by a mechanism which differs from DNA damage checkpoint control. Bartz SR, Rogel ME, Emerman M, J Virol 1996 70 2324 2331 8642659
23. HIV-1 viral infectivity factor interacts with TP53 to induce G2 cell cycle arrest and positively regulate viral replication. Izumi T, Io K, Matsui M, Shirakawa K, Shinohara M, Nagai Y, Kawahara M, Kobayashi M, Kondoh H, Misawa N, Koyanagi Y, Uchiyama T, Takaori-Kondo A, Proc Natl Acad Sci USA 2010 107 20798 20803 10.1073/pnas.1008076107 21071676
24. HIV-1 Vpr induces defects in mitosis, cytokinesis, nuclear structure, and centrosomes. Chang F, Re F, Sebastian S, Sazer S, Luban J, Mol Biol Cell 2004 15 1793 1801 10.1091/mbc.E03-09-0691 14767062
25. HIV-1 Vpr increases viral expression by manipulation of the cell cycle: a mechanism for selection of Vpr in vivo. Goh WC, Rogel ME, Kinsey CM, Michael SF, Fultz PN, Nowak MA, Hahn BH, Emerman M, Nat Med 1998 4 65 71 10.1038/nm0198-065 9427608
26. Chronic immune activation in the T cell compartment of HCV/HIV-1 co-infected patients. Sandberg JK, Falconer K, Gonzalez VD, Virulence 2010 1 177 179 10.4161/viru.1.3.11206 21178437
27. NF-kappaB/Rel: agonist and antagonist roles in HIV-1 latency. Chan JK, Greene WC, Curr Opin HIV AIDS 2011 6 12 18 10.1097/COH.0b013e32834124fd 21242888
28. HIV and HCV cooperatively promote hepatic fibrogenesis via induction of reactive oxygen species and NFkappaB. Lin W, Wu G, Li S, Weinberg EM, Kumthip K, Peng LF, Mendez-Navarro J, Chen WC, Jilg N, Zhao H, Goto K, Zhang L, Brockman MA, Schuppan D, Chung RT, J Biol Chem 2011 286 2665 2674 10.1074/jbc.M110.168286 21098019
29. Hostile takeovers: viral appropriation of the NF-kappaB pathway. Hiscott J, Kwon H, Genin P, J Clin Invest 2001 107 143 151 10.1172/JCI11918 11160127
30. HIV-1 Vpr activates both canonical and noncanonical NF-kappaB pathway by enhancing the phosphorylation of IKKalpha/beta. Liu R, Tan J, Lin Y, Jia R, Yang W, Liang C, Geng Y, Qiao W, Virology 2013 439 47 56 10.1016/j.virol.2013.01.020 23453579
31. Gene expression profile of HIV-1 Tat expressing cells: a close interplay between proliferative and differentiation signals. de la Fuente C, Santiago F, Deng L, Eadie C, Zilberman I, Kehn K, Maddukuri A, Baylor S, Wu K, Lee CG, Pumfery A, Kashanchi F, BMC Biochem 2002 3 14 10.1186/1471-2091-3-14 12069692
32. Serial changes in expression of functionally clustered genes in progression of liver fibrosis in hepatitis C patients. Takahara Y, Takahashi M, Zhang QW, Wagatsuma H, Mori M, Tamori A, Shiomi S, Nishiguchi S, World J Gastroenterol 2008 14 2010 2022 10.3748/wjg.14.2010 18395900
33. Transcriptome sequencing, microarray, and proteomic analyses reveal cellular and metabolic impact of hepatitis C virus infection in vitro. Woodhouse SD, Narayan R, Latham S, Lee S, Antrobus R, Gangadharan B, Luo S, Schroth GP, Klenerman P, Zitzmann N, Hepatology 2010 52 443 453 10.1002/hep.23733 20683944
34. Genome-wide analysis of primary CD4+ and CD8+ T cell transcriptomes shows evidence for a network of enriched pathways associated with HIV disease. Wu JQ, Dwyer DE, Dyer WB, Yang YH, Wang B, Saksena NK, Retrovirology 2011 8 18 10.1186/1742-4690-8-18 21410942
35. Clarifying the role of G protein signaling in HIV infection: new approaches to an old question. Juno JA, Fowke KR, AIDS Rev 2010 12 164 176 20842205
36. Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function. Kristiansen K, Pharmacol Ther 2004 103 21 80 10.1016/j.pharmthera.2004.05.002 15251227
37. Hepatitis C virus induces the expression of CCL17 and CCL22 chemokines that attract regulatory T cells to the site of infection. Riezu-Boj JI, Larrea E, Aldabe R, Guembe L, Casares N, Galeano E, Echeverria I, Sarobe P, Herrero I, Sangro B, Prieto J, Lasarte JJ, J Hepatol 2011 54 422 431 10.1016/j.jhep.2010. 07.014 21129807
38. Sensitization of adenylate cyclase by Galpha i/o-coupled receptors. Watts VJ, Neve KA, Pharmacol Ther 2005 106 405 421 10.1016/j.pharmthera.2004.12.005 15922020
39. cAMP during HIV infection: friend or foe? Moreno-Fernandez ME, Rueda CM, Velilla PA, Rugeles MT, Chougnet C, AIDS Res Hum Retroviruses 2012 28 1 49 53 10.1089/aid.2011.0265 21916808
40. Extracellular ATP reduces HIV-1 transfer from immature dendritic cells to CD4+ T lymphocytes. Barat C, Gilbert C, Imbeault M, Tremblay MJ, Retrovirology 2008 5 30 10.1186/1742-4690-5-30 18373845
41. Modulation of HIV-1 enhancer activity and virus production by cAMP. Banas B, Eberle J, Schlondorff D, Luckow B, FEBS Lett 2001 509 207 212 10.1016/S0014-5793(01)03182-9 11741590
42. Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression. Bopp T, Becker C, Klein M, Klein-Hessling S, Palmetshofer A, Serfling E, Heib V, Becker M, Kubach J, Schmitt S, Stoll S, Schild H, Staege MS, Stassen M, Jonuleit H, Schmitt E, J Exp Med 2007 204 1303 1310 10.1084/jem.20062129 17502663
43. Restoration of T-cell function in HIV infection by reduction of intracellular cAMP levels with adenosine analogues. Hofmann B, Nishanian P, Nguyen T, Liu M, Fahey JL, AIDS 1993 7 659 664 10.1097/00002030-199305000-00008 8391271
44. Microarray analysis of human leucocyte subsets: the advantages of positive selection and rapid purification. Lyons PA, Koukoulaki M, Hatton A, Doggett K, Woffendin HB, Chaudhry AN, Smith KG, BMC Genomics 2007 8 64 10.1186/1471-2164-8-64 17338817
45. Statistical implications of pooling RNA samples for microarray experiments. Peng X, Wood CL, Blalock EM, Chen KC, Landfield PW, Stromberg AJ, BMC Bioinforma 2003 4 26 10.1186/1471-2105-4-26